AUPH יתרות המזומנים של החברה Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals (AUPH) faces single-product dependency and regulatory pressure, yet demand for nephritis treatment renders the business crisis-resistant. This chart displays the cash balance based on GURU.Markets data, where the 0.49 level indicates the status of the liquidity parameter. The company is currently undergoing rigorous restructuring and workforce optimization following unsuccessful attempts to sell the business.
פילוחי מדדים פיננסיים ומדדי שוק עבור Aurinia Pharmaceuticals Inc (AUPH)

For Aurinia Pharmaceuticals (AUPH), the cash flow chart reflects the financial foundation for implementing robotic packaging lines and bioanalytical stations. This indicator measures the total liquid reserve, allowing for an assessment of the balance between the business's operational resilience during periods of volatility and the risk of excess capital depreciation due to inflationary processes, which directly impacts the final return on assets.